Investor Meeting on Q1 FY2019 Results

from the beginning

Conference Call on Q1 FY2019 Results

Presenter：

Shigeo Taniuchi
President & Chief Operating Officer

• Santen's Values and Mission Statement

• MTP2020 Fundamental Policy and Strategic Goals

• Q1 FY2019 Highlights

Q1 FY2019 Financial Results ended June 30, 2019

Presenter：

Satoshi Suzuki
Senior Corporate Officer, Head of Corporate Development Division

• Q1 FY2019 Financial Overview (year-on-year comparisons)

• Q1 FY2019 Revenue

• Q1 FY2019 Core Operating Profit

• Performance by Business (Japan)

• Performance by Business (Asia)

• Performance by Business (EMEA)

• FY2019 Forecast Overview (No change from May 9)

• FY2019 Forecast (No change from May 9)

• FY2019 Dividend Forecast (No change from May 9)

Status pf Research & Development

Presenter：

Naveed Shams, M.D., Ph.D.
Senior Corporate Officer, Chief Scientific Officer

• Pipeline / Product Development Status(1)

• Pipeline / Product Development Status(2)

Appendix

• Q1 FY2019 Profit and Loss Statement

• Q1 FY2019 Financial Position

• Q1 FY2019 Segment Revenue

• Capital Expenditures / Depreciation & Amortizetion

• Prescription Ophthalmic Market in Japan

• Revenue by Area Q1 FY2019

Forward-Looking Statements

@

Q&A

• Q&A 1

• Q&A 2

• Q&A 3

• Q&A 4

• Q&A 5

• Q&A 6